Avanos Medical (AVNS) Asset Writedowns and Impairment (2024)
Avanos Medical (AVNS) posted Asset Writedowns and Impairment of $336.5 million for Q4 2024.
Avanos Medical (AVNS) Asset Writedowns and Impairment (2024) Analysis & Trends
Avanos Medical has reported Asset Writedowns and Impairment for 1 years, with the latest figure at $336.5 million in Q4 2024.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $336.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $336.5 million (changed N/A YoY) and the FY2025 annual result came in at $77.0 million, down 82.37% from the prior year.
- Asset Writedowns and Impairment was little changed at $336.5 million in Q4 2024 per AVNS's latest filing.
- Over five years, Asset Writedowns and Impairment peaked at $336.5 million in Q4 2024 and troughed at $336.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 336.50 Mn |
| Dec 31, 2024 | 336.50 Mn |